US FDA panel says silicone breast implants are safe but calls for better post-marketing surveillance
This article was originally published in SRA
Executive Summary
A US Food and Drug Administration advisory panel has decided that silicone breast implants are safe and will remain on the market, but said it would consider creating a registry to track safety issues, after finding that manufacturers had failed to adequately track the problems themselves1, 2.